Trial Profile
Changes of airway protective function during recovery of general anesthesia
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 07 Dec 2018
Price :
$35
*
At a glance
- Drugs Neostigmine (Primary) ; Sugammadex (Primary)
- Indications Anaesthesia; Neuromuscular blockade
- Focus Therapeutic Use
- 03 Dec 2018 Status changed from recruiting to completed.
- 24 May 2016 New trial record